Immune-checkpoint inhibitors in brain metastases from renal cell carcinoma: a battle was lost but not the war.
作者信息
Lombardi Giuseppe, Maruzzo Marco, Minniti Giuseppe, Padovan Marta, Caccese Mario, Zagonel Vittorina
机构信息
Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Radiation Oncology Unit, UPMC Hillman Cancer Center, San Pietro Hospital FBF, Rome, Italy.
出版信息
Ann Transl Med. 2019 Sep;7(Suppl 6):S222. doi: 10.21037/atm.2019.08.42.
Abstract
摘要
相似文献
1
Immune-checkpoint inhibitors in brain metastases from renal cell carcinoma: a battle was lost but not the war.
Ann Transl Med. 2019 Sep;7(Suppl 6):S222. doi: 10.21037/atm.2019.08.42.
2
Immune Checkpoint Inhibitors in Brain Metastases: From Biology to Treatment.
Am Soc Clin Oncol Educ Book. 2016;35:e116-22. doi: 10.1200/EDBK_100005.
3
Management of Brain Metastases in the New Era of Checkpoint Inhibition.
Curr Neurol Neurosci Rep. 2018 Aug 18;18(10):70. doi: 10.1007/s11910-018-0877-8.
4
Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):916-925. doi: 10.1016/j.ijrobp.2017.11.041. Epub 2017 Dec 5.
5
Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.
Cancer Treat Rev. 2020 Sep;89:102067. doi: 10.1016/j.ctrv.2020.102067. Epub 2020 Jul 7.
6
Immune Checkpoint Inhibitors for Brain Metastases.
Curr Oncol Rep. 2017 Jun;19(6):38. doi: 10.1007/s11912-017-0596-3.
7
[Not Available].
Bull Cancer. 2018 Dec;105 Suppl 3:S261-S267. doi: 10.1016/S0007-4551(18)30381-3.
8
Expected Paradigm Shift in Brain Metastases Therapy-Immune Checkpoint Inhibitors.
Mol Neurobiol. 2018 Aug;55(8):7072-7078. doi: 10.1007/s12035-018-0905-3. Epub 2018 Jan 30.
9
A comprehensive review of the role of immune checkpoint inhibitors in brain metastasis of renal cell carcinoma origin.
Crit Rev Oncol Hematol. 2018 Oct;130:60-69. doi: 10.1016/j.critrevonc.2018.08.001. Epub 2018 Aug 7.
10
Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma.
Drugs. 2018 Sep;78(14):1443-1457. doi: 10.1007/s40265-018-0970-y.
引用本文的文献
1
An Overview of Systemic Targeted Therapy in Renal Cell Carcinoma, with a Focus on Metastatic Renal Cell Carcinoma and Brain Metastases.
Curr Issues Mol Biol. 2023 Sep 21;45(9):7680-7704. doi: 10.3390/cimb45090485.
2
Second-line treatment in renal cell carcinoma: clinical experience and decision making.
Ther Adv Urol. 2021 Jun 18;13:17562872211022870. doi: 10.1177/17562872211022870. eCollection 2021 Jan-Dec.
3
Musashi1 expression is negatively correlated with numb expression in brain metastases.
Medicine (Baltimore). 2020 Oct 23;99(43):e22000. doi: 10.1097/MD.0000000000022000.
本文引用的文献
1
Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial.
JAMA Oncol. 2019 Sep 1;5(9):1276-1282. doi: 10.1001/jamaoncol.2019.1478.
2
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.
J Clin Oncol. 2019 Aug 10;37(23):2008-2016. doi: 10.1200/JCO.18.02218. Epub 2019 Jun 13.
3
Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World Population.
Clin Genitourin Cancer. 2019 Aug;17(4):291-298. doi: 10.1016/j.clgc.2019.05.002. Epub 2019 May 13.
4
Brain Complete Response to Cabozantinib prior to Radiation Therapy in Metastatic Renal Cell Carcinoma.
Case Rep Urol. 2019 Feb 13;2019:6769017. doi: 10.1155/2019/6769017. eCollection 2019.
5
Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer.
Lung Cancer. 2019 Mar;129:35-40. doi: 10.1016/j.lungcan.2018.12.025. Epub 2019 Jan 15.
6
Brain metastases.
Nat Rev Dis Primers. 2019 Jan 17;5(1):5. doi: 10.1038/s41572-018-0055-y.
7
Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes.
Radiother Oncol. 2018 Aug;128(2):266-273. doi: 10.1016/j.radonc.2018.06.017. Epub 2018 Jun 27.
8
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.
Lancet Oncol. 2018 May;19(5):672-681. doi: 10.1016/S1470-2045(18)30139-6. Epub 2018 Mar 27.
9
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
N Engl J Med. 2018 Apr 5;378(14):1277-1290. doi: 10.1056/NEJMoa1712126. Epub 2018 Mar 21.
10
Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression.
Oncotarget. 2017 Oct 23;8(61):103428-103436. doi: 10.18632/oncotarget.21952. eCollection 2017 Nov 28.
Zotero 插件